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ARTICLE
Regulation of mycobacterial infection by
macrophage Gch1 and tetrahydrobiopterin
Eileen McNeill 1,2, Elena Stylianou 3, Mark J. Crabtree 1,2, Rachel Harrington-Kandt3, Anna-Lena Kolb1,2,
Marina Diotallevi1,2, Ashley B. Hale1,2, Paulo Bettencourt3, Rachel Tanner3, Matthew K. O’Shea3,
Magali Matsumiya3, Helen Lockstone2, Julius Müller 3, Helen A. Fletcher 4, David R. Greaves5,
Helen McShane3 & Keith M. Channon1,2
Inducible nitric oxide synthase (iNOS) plays a crucial role in controlling growth of Myco-
bacterium tuberculosis (M.tb), presumably via nitric oxide (NO) mediated killing. Here we
show that leukocyte-speciﬁc deﬁciency of NO production, through targeted loss of the iNOS
cofactor tetrahydrobiopterin (BH4), results in enhanced control of M.tb infection; by contrast,
loss of iNOS renders mice susceptible to M.tb. By comparing two complementary NO-
deﬁcient models, Nos2−/− mice and BH4 deﬁcient Gch1ﬂ/ﬂTie2cre mice, we uncover
NO-independent mechanisms of anti-mycobacterial immunity. In both murine and human
leukocytes, decreased Gch1 expression correlates with enhanced cell-intrinsic control of
mycobacterial infection in vitro. Gene expression analysis reveals that Gch1 deﬁcient mac-
rophages have altered inﬂammatory response, lysosomal function, cell survival and cellular
metabolism, thereby enhancing the control of bacterial infection. Our data thus highlight the
importance of the NO-independent functions of Nos2 and Gch1 in mycobacterial control.
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Tuberculosis (TB) remains a signiﬁcant global health pro-blem that kills more people than any other infectiousdisease, with>10 million new cases and 1.8 million deaths
annually1. Chronic HIV co-infection and the treatment of
chronic inﬂammatory conditions such as rheumatoid arthritis
with potent immune modulators such as anti-TNF biologics, has
revealed latent Mycobacterium tuberculosis (M.tb) infection
reactivation as another growing source of TB disease burden,
compounded by the global rise of drug-resistant TB. Thus, the
discovery of new treatments for TB remains a pressing priority. In
particular, augmenting host anti-mycobacterial mechanisms to
enhance pathogen control through host-directed therapies
(HDTs) is an area of intense interest. Identiﬁcation of novel
innate pathways and mechanisms could yield important insights
that would lead to new therapeutic strategies.
Progress in the identiﬁcation of genetic factors involved in TB
susceptibility has been limited but the importance of some genes
is already clear2. Polymorphisms in inducible nitric oxide syn-
thase (iNOS, encoded by NOS2)3 confer important differences in
the control of mycobacterial infection. Mice deﬁcient in iNOS
show variability in the timing of loss of control of mycobacterial
infection in experimental models, however, in all published stu-
dies to date Nos2−/− mice show increased susceptibility at later
time points. Nos2−/− mice succumb to infection with intravenous
Mycobacterium bovis Bacillus Calmette Guerin (BCG) after
8–12 weeks, in contrast to wildtype mice that are able to control
infection4. Furthermore, iNOS-deﬁcient mice infected with the
more virulent M.tb Erdman succumb more rapidly than control
mice in both intravenous and aerosol challenge experiments, even
if early control of infection is maintained in short challenges5–7.
Thus, iNOS is a pivotal regulator of susceptibility to M.tb infec-
tion in mice. These effects of iNOS have been associated with the
production of nitric oxide (NO), largely because of in vitro cor-
relations between the mycobacteriocidal activity of activated
murine macrophages and the amount of reactive nitrogen inter-
mediates (RNI) produced8,9 and the direct cytotoxicity of nitric
oxide to mycobacteria10.
The concept that NO, and thus iNOS, acts only to kill myco-
bacteria in infected macrophages overlooks the more recent
advances in the understanding of NO and NOS-dependent
nitroso-redox signaling. NO can mediate reduced susceptibility to
infection by modulating a range of host cell functions including
induction of cell apoptosis or necrosis, control of phagosome
maturation, effects on iron metabolism and signaling to the
adaptive immune system11. Many of these functions are mediated
by nitric oxide and RNI as signaling molecules, transducing their
signal through protein modiﬁcations such as nitrosylation of
cysteine residues or protein nitration. However, iNOS may also
have nitric oxide-independent functions. The NOS cofactor tet-
rahydrobiopterin (BH4) is essential for NO production and sta-
bilizes iNOS dimer formation12. Under BH4 replete conditions
the NOS isoforms generate NO by oxidation of the amino acid L-
arginine by molecular oxygen, forming L-citrulline13. NOS
enzymes function in an ‘uncoupled’ state in the absence of BH4,
whereby L-arginine is not oxidized to NO and superoxide is
produced by the reductase domain of the enzyme. Whilst most
attention on NOS uncoupling has been focused on endothelial
NOS14,15, we have demonstrated more recently that macrophage
BH4 regulates production of reactive oxygen species, and impacts
nitroso-redox dependent gene expression16. iNOS also demon-
strates direct protein–protein interactions with a number of
proteins including those with ribosomal and metabolic func-
tions17 indicating that the ability of this protein to inﬂuence cell
biology is much wider than through NO-production alone.
The human biology of iNOS and NO in tuberculosis is con-
troversial18–20. Although detection of functional iNOS in patients
with inﬂammatory conditions such as tuberculosis has been
documented21,22, the ability of human macrophages to produce
nitric oxide in vitro is less clear. However, an often overlooked
aspect of human macrophage biology is their limited BH4 con-
tent23. How macrophage iNOS functions under conditions of
limiting BH4 supply serves as a unique model of human infection,
and alterations in disease processes under these conditions may
reveal ﬁndings of particular relevance to human therapeutics in
comparison to experimental models in wildtype mice where a
fulminant NO response is seen.
BH4 is produced by a multistep pathway involving three
enzymes; GTP cyclohydrolase-1 (GTPCH-1), pyrovoyl tetra-
hydropterin synthase (PTPS) and sepiapterin reductase (SR)23.
GTPCH-1, encoded by Gch1, is involved in the initial and rate-
limiting step of BH4 synthesis24. We have generated a conditional
knockout mouse with Gch1 deletion in leukocytes, preventing
BH4 biosynthesis25.
Here we demonstrate that mice deﬁcient in NO production,
through either loss of iNOS protein or the essential NOS co-factor
BH4 show divergent phenotypes of susceptibility vs enhanced
control of mycobacterial infection both in vivo and in vitro. Using
genomic analysis, we identify a gene signature, unique to the loss
of BH4 and distinct from the loss of iNOS protein, that is asso-
ciated with enhanced control of mycobacterial infection. These
results demonstrate that NO-independent mechanisms of bac-
terial control by iNOS and BH4 have pathological importance
and therapeutic potential in human disease.
Results
iNOS+ Gch1ﬂ/ﬂTie2cre macrophages do not produce NO. We
generated matched litters of Gch1ﬂ/ﬂTie2cre and Gch1ﬂ/ﬂ mice
(hereafter referred to as wildtype), and conﬁrmed that Gch1ﬂ/ﬂTie2cre
mice lack Gch1 expression in hematopoietic cells (Supplementary
Figure 1a–c). In vitro infection of macrophages with BCG (Pasteur)
alone showed minimal induction of Nos2, however in the presence of
IFNγ infection with BCG caused a robust induction of Nos2 and
accumulation of nitrite, indicating robust iNOS NO-producing
activity (Fig. 1a). The speciﬁcity of nitrite accumulation for iNOS
activity was conﬁrmed by infection of Nos2−/− BMDM under iden-
tical conditions (Supplementary Figure 2). BCG/IFNγ treatment
caused increased cellular BH4 content in wildtype mice, with BH4
levels and GTPCH protein signiﬁcantly reduced to near undetectable
levels in the Gch1ﬂ/ﬂTie2cre cells (Figure 1b, c). Loss of BH4 did not
affect induction of iNOS protein (Fig. 1b), but prevented iNOS NO-
producing activity measured as nitrite accumulation,
arginine–citrulline conversion and direct detection of authentic NO
generation by EPR (Fig. 1d–f). In order to test whether iNOS protein
had other non-NO-producing roles in mycobacterial function the
BCG/IFNγ combination was used in all in vitro studies to cause
robust iNOS expression. These data conﬁrm that whilst iNOS protein
is induced in macrophages infected with BCG, in the absence of the
co-factor BH4 no nitric oxide is produced, providing a system to
discriminate iNOS functions reliant speciﬁcally on nitric oxide
production.
Whilst nitric oxide production was absent, production of ROS
was signiﬁcantly increased in Gch1ﬂ/ﬂTie2cre macrophages both
at baseline (1.6 fold) and following BCG infection (3.2 fold) when
assessed by the production of ethidium from dihydroethidium
(Fig. 1g). This indicates that the loss of BH4 causes alterations in
cellular redox state in both the presence and absence of iNOS.
Macrophages have multiple potential sources of ROS, including
the phagocytic NADPH oxidase that mediate oxidative burst and
mitochondrial metabolism. To assess more broadly how ROS
production by infected macrophages was affected, the phagocytic
oxidative burst was assessed by ﬂow cytometry using the CellROX
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indicator dye26. BMDM were infected with BCG-GFP27 and the
ROS production was assessed in infected BCG-GFP+ vs
uninfected BCG-GFP− cells 2 h after initial infection with
BCG-GFP/IFNγ. Whilst a signiﬁcant induction of ROS produc-
tion was observed, this was not signiﬁcantly affected by loss of
BH4 (Supplementary Figure 3a). To further examine redox
changes in response to infection we measured the extracellular
release of H2O2, which is induced by infection and was
undetectable in uninfected cells, this was signiﬁcantly reduced
in the Gch1ﬂ/ﬂTie2cre cells (Supplementary Figure 3b) indicating
that the changes in redox biology elicited by the loss of BH4 in
macrophages is substantially more complex than has been
observed in other BH4 deﬁcient cell types28. Whilst in endothelial
cells ROS production is elevated as a result of eNOS uncoupling
in the absence of BH4, in macrophages BH4 deﬁciency results in
more widespread changes, but with the phagocytic oxidative burst
in response to infection appearing unchanged.
Gch1ﬂ/ﬂTie2cre macrophages are BH4 and NO-deﬁcient
in vivo. To assess whether the loss of NO-production had bio-
logical consequences in vivo it was important to demonstrate that
the cells remained deﬁcient in both BH4 and NO-production
even in an environment where other cells were replete in BH4
levels. We conﬁrmed Gch1 deletion rendered inﬂammatory cells
BH4 deﬁcient in vivo, by inducing sterile peritonitis in mice using
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Fig. 1 Characterisation of the in vitro mycobacterial infection of Gch1ﬂ/ﬂ Tie2cre macrophages. a Measurement of Nos2 and nitrite accumulation in bone
marrow-derived macrophages stimulated with BCG (MOI 1:1) or IFNγ (10 ng/ml) and BCG (MOI 1:1) for 24 h in wildtype macrophages (n= 6). bWestern
blotting showing GTPCH and iNOS protein expression in Gch1ﬂ/ﬂTie2cre macrophages, compared to wildtype (WT) macrophages at baseline and following
infection with IFNγ (10 ng/ml) and BCG (MOI 1:1) for 24 h. Equal protein loading was demonstrated by detection of β-tubulin. c Measurement of BH4
(pmol mg−1 protein) in bone marrow-derived macrophages (n= 4, p < 0.05). UT uninfected. d Nitrite accumulation in the cell culture media over 24 h of
cell stimulation with BCG/IFNγ as before was measured using the Griess assay (n= 3/genotype). ND not detectable. e Quantiﬁcation of the NMA-
inhibitable arginine to citrulline conversion (n= 8, p < 0.05). f Representative EPR spectra from n= 4/genotype WT and Gch1ﬂ/ﬂTie2cre macrophages
following activation with IFNγ (10 ng/ml) and BCG (MOI 1:1). g Cells were incubated with dihydroethidium for the last 30min of culture and ethidium
production was measured in cell lysates by HPLC (n= 3/genotype). h Flow cytometry dotplot demonstrating identiﬁcation of neutrophils (7/4HI, Ly-6GHI)
and inﬂammatory monocytes (7/4HI, Ly-6G−) in lavage ﬂuid from wildtype animals 6 h after injection with 1 mg zymosan ip. i The recruitment of
monocytes and neutrophils by zymosan or saline control injection into wildtype and Gchﬂ/ﬂTie2cre animals was quantiﬁed by ﬂow cytometry in the
peritoneal lavage 6 h later (n= 6 control groups, n= 5 Gch1ﬂ/ﬂ Zymosan, n= 6 Gch1ﬂ/ﬂTie2cre Zymosan). Lavage ﬂuid was further analysed for total nitrite
and nitrate (NOx) content by NO analyzer (j) and total biopterin content (k) (n= 5 Gch1ﬂ/ﬂ Control, n= 2 Gch1ﬂ/ﬂTie2cre Control, n= 5 Gch1ﬂ/ﬂ Zymosan,
n= 6 Gch1ﬂ/ﬂTie2cre Zymosan, p < 0.05). l The elicited peritoneal cells were assayed for BH4 content (n= 4 per group, two-tailed t-test, p < 0.05). All
data analysed by one-way or two-way (genotype experiments) ANOVA with Bonferroni post-test unless otherwise stated above. All ‘n’ represent individual
biological replicates, including cell cultures from individual animals/genotype. Data shown as individual data-points with mean and SEM. *p < 0.05,
**p < 0.01, ***p < 0.001. Source blot and ﬂow cytometry data are available in Supplementary Figure 10 and 11
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zymosan, to induce iNOS in recruited peritoneal exudate cells29.
Recruitment of neutrophils and monocytes to the peritoneal
cavity (Fig. 1h) was unaffected by Gch1 deletion (Fig. 1i)25.
Analysis of peritoneal lavage ﬂuid in wildtype mice revealed that
zymosan caused signiﬁcant induction of the iNOS and tetra-
hydrobiopterin pathway, measured by total biopterins and nitrite/
nitrate levels (NOx), stable oxidized extracellular endproducts of
nitric oxide production in vivo (Fig. 1j, k). Total biopterins (BH4,
dihydrobiopterin and biopterin) rather than BH4 were assessed
due to the oxidizing nature of extracellular environment causing
oxidative loss of BH4 to the oxidized forms dihydrobiopterin and
biopterin. In contrast, no signiﬁcant elevation of biopterins or
NOx levels were evident in peritoneal lavage ﬂuid from Gch1ﬂ/
ﬂTie2cre mice. Furthermore, peritoneal leukocytes from Gch1ﬂ/
ﬂTie2cre animals showed barely detectable levels of intracellular
BH4, in contrast to wildtype cells (Fig. 1l) indicating that Gch1ﬂ/
ﬂTie2cre leukocytes remain BH4 deﬁcient in vivo and are not
rescued by systemic BH428.
Gch1ﬂ/ﬂTie2cre mice have enhanced control of BCG infection.
Given the importance of iNOS in mycobacterial infection in mice,
we next investigated the consequences of BH4 deﬁciency on
mycobacterial infection in vivo, comparing wildtype with Gch1ﬂ/
ﬂTie2cre mice. We conﬁrmed that peripheral blood leukocyte
homeostasis was not altered in Gch1ﬂ/ﬂTie2cre mice (Supple-
mentary Figure 4a-d) and that Gch1ﬂ/ﬂTie2cre alveolar macro-
phages from bronchoalveolar lavage were deleted for Gch1
(Fig. 2a), and had undetectable BH4 levels (Fig. 2b). We infected
wildtype and Gch1ﬂ/ﬂTie2cre mice with BCG by intranasal
instillation, and monitored the infected mice for 4 weeks. Both
wildtype and Gch1ﬂ/ﬂTie2cre mice had comparable lung bacterial
load, but CFU counts were signiﬁcantly lower in the Gch1ﬂ/ﬂ
Tie2cre spleens compared to wildtype mice littermates (Fig. 2c,
d). BCG infection induced a signiﬁcant increase in spleen:body
weight ratio in Gch1ﬂ/ﬂTie2cre mice, and a non-signiﬁcant
increase in wildtype animals (Fig. 2e). Measurement of total
biopterins in the lung and spleen homogenate showed a sig-
niﬁcant increase in infected wildtype lungs compared to un-
infected controls (Fig. 2f). Total biopterin levels rather than BH4
alone were assessed due to the oxidizing nature of the homo-
genisation process required for BCG CFU assessment. The levels
of total biopterins in the lung and spleen of infected mice were
signiﬁcantly lower in the Gch1ﬂ/ﬂTie2cre mice than the wildtype
controls (Fig. 2f, g). The total biopterin content of BCG-infected
lungs was signiﬁcantly correlated with lung mycobacterial load
(Fig. 2h), consistent with BH4 deﬁciency resulting in control of
infection. BCG infection induced iNOS in the infected lung tis-
sues from mice of both genotypes (Fig. 2i), but NOx in lung
lysates was signiﬁcantly lower in infected Gch1ﬂ/ﬂTie2cre mice
(Fig. 2j).
Loss of NO but not iNOS protein reduces M.tb infection. To
more stringently assess the role of macrophage nitric oxide pro-
duction in a more pathogenic model we evaluated the effect of
macrophage BH4 deﬁciency on the response to a virulent aero-
solized M.tb challenge in Gch1ﬂ/ﬂTie2cre mice. To directly com-
pare the effects of total iNOS deﬁciency with deﬁcient iNOS-
mediated NO production, we also infected Nos2−/− and control
C57BL/6J mice under the same conditions. Inclusion of this
control group was of particular importance given the variability
in onset of susceptibility seen in previous studies5–7. As expected,
Nos2−/− mice developed dramatic macroscopic lung and spleen
pathology after M.tb infection, with numerous large lung gran-
ulomatous lesions and splenomegaly (Fig. 3a and Supplementary
Figure 5). In contrast, none of these features were prominent in
either the Gch1ﬂ/ﬂTie2cre or the wildtype animals. Both wildtype
control mice and Gch1ﬂ/ﬂTie2cre mice gained weight over
4 weeks after infection (Fig. 3b). In contrast, Nos2−/− mice
showed a steady decline in weight from 2 weeks post-infection,
and required termination of the experiment 23 days post-
infection at a pre-speciﬁed humane endpoint. The Nos2−/− mice
had signiﬁcantly higher lung and spleen CFU counts than the
C57BL/6J control group (Fig. 3c, d), whereas CFU counts in the
Gch1ﬂ/ﬂTie2cre mice were not different from their wildtype lit-
termate controls. Body weight correlated with lung CFU counts in
individual animals (Fig. 3e), with Gch1ﬂ/ﬂTie2cre mice having
highest bodyweights, in keeping with the lowest lung CFU.
Immunohistochemistry of lung granuloma conﬁrmed iNOS
expression and macrophage inﬁltration within the granulomata of
wildtype and Gch1ﬂ/ﬂTie2cre mice that was absent in Nos2−/−
mice (Fig. 3a and Supplementary Figure 6).
To further assess the control of M.tb infection in Gch1ﬂ/ﬂTie2cre
mice, we undertook more prolonged infection experiments. Six
weeks after infection with aerosolized M.tb, Gch1ﬂ/ﬂTie2cre mice
had signiﬁcantly lower CFU per lung than their wildtype littermate
controls (Fig. 3f). Spleen CFU counts were comparable between
groups (Fig. 3g). Whilst the reduced extrapulmonary spread of
infection, seen when mice were infected with BCG, was not
maintained when Gch1ﬂ/ﬂTie2cre mice are exposed to the more
virulentM.tb infection, this stringent test of susceptibility shows a
clear reduced susceptibility in the lung at a later 6-week
timepoint. As expected, Gch1 gene expression in the infected
Gch1ﬂ/ﬂTie2cre tissues (Supplementary Figure 7) was signiﬁcantly
lower whereas expression of other key inﬂammatory genes, Nos2,
Tnfα and Cd68, were unaffected, indicating preservation of the
inﬂammatory response.
Gene expression reveals signature unique to loss of Gch1. Due
to the multiple changes in the redox biology of the BH4 deﬁcient
macrophages we next sought to use gene expression analysis
to gain insight into the mechanism of the enhanced control
of mycobacterial infection observed in Gch1-deleted, BH4-
deﬁcient macrophages. We performed a mouse whole genome
array analysis on Gch1ﬂ/ﬂTie2cre and Nos2−/− macrophages,
infected with BCG in the presence of IFNγ for 24 h (to induce
robust iNOS expression), compared with control uninfected
macrophages for each genotype. This experimental design enables
us to speciﬁcally compare the conditions of loss of iNOS and loss
of iNOS-mediated NO-production in the context of BH4
deﬁciency.
We identiﬁed differentially expressed genes in response to
BCG/IFNγ in wildtype mice. As expected, BCG/IFNγ caused
major changes in macrophage gene expression proﬁles, with
12,412 probes being differentially expressed (Supplementary
Data 1). Heatmap analysis of the 1000 most regulated genes
showed a consistent activation across all genotypes (Supplemen-
tary Figure 8). Pathway analysis of the most signiﬁcantly
regulated genes, using the Ingenuity Pathway Analysis (IPA)
tool, indicated activation of pathways associated with inﬂamma-
tion and infection (Supplementary Figure 8 and Supplementary
Data 2) as expected.
We next compared the effect of loss of Gch1 and Nos2 in both
BCG/IFNγ treated and uninfected macrophages. We observed
only minor variation in uninfected macrophages between Gch1ﬂ/
ﬂTie2cre and Nos2−/− macrophages and their controls, with only
77 and 26 probes, respectively, being differentially expressed
(Fig. 4a and Supplementary Data 3). In contrast, when infected
with BCG, 779 (Gch1ﬂ/ﬂTie2cre vs Gch1ﬂ/ﬂ) and 172 (Nos2−/− vs
Nos2+/+) probes showed differential expression (Fig. 4a and
Supplementary Data 3), with 737 probes being unique to the gene
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list for infected Gch1ﬂ/ﬂTie2cre macrophages. IPA pathway
analysis revealed signiﬁcant activation, in Gch1ﬂ/ﬂTie2cre macro-
phages, of key functions relating to cell–cell signaling, inﬂam-
matory response and lipid metabolism (Fig. 4b, c). In particular,
Gch1 deletion up-regulated pathways regulating myeloid cell
recruitment, neutrophil activation, phagocyte degranulation, and
sterol synthesis, whereas cell death and apoptosis of leukocytes
were signiﬁcantly down-regulated (Fig. 4b, c, Supplementary
Data 4). Analysis of potential upstream regulators identiﬁed
enhanced signaling via TLRs 2/4/5/9 and inﬂammatory cytokine/
cytokine receptors including IL1, TNF superfamily, and CCL5
(Fig. 4d, Supplementary Data 5). These data indicated that part of
the inﬂammatory response to infection appeared to be enhanced
in the BH4 deﬁcient macrophages. We validated the presence of
genes that show regulation only as a result of BH4 deﬁciency
(As3mt) and as a result of loss of both BH4 and iNOS (Slc40a1) in
our gene array study in an independent cohort of cells (Fig. 5).
These data conﬁrmed the gene expression changes observed in
our earlier study of LPS/IFNγ stimulated macrophages, with the
identiﬁcation of similar gene expression changes in both As3mt
and Slc40a125 and a similar prediction of decreased NRF2-
mediated gene expression (Fig. 4d). However, it also demon-
strated striking divergence regulation of key genes such as IL-6
which showed decreased activation following LPS/IFNγ treatment
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but enhanced expression following BCG/IFNγ treatment (Fig. 4c),
indicating exposure to a live pathogen causes a unique pattern of
gene regulation that cannot be adequately modelled by the use of
other proinﬂammatory stimuli.
To more broadly evaluate the entire dataset, we performed
unsupervised Gene Set Enrichment Analysis (GSEA) to identify
coordinated regulation of annotated groups of genes, implicated
in deﬁned cellular processes30. We performed Preranked GSEA
using the GO term-deﬁned gene sets relating to biological
processes (MSigDB C5 BP) followed by network analysis of the
most signiﬁcantly altered gene sets using Enrichment Map30
(Fig. 6a, b, Supplementary Data 6). We then compared the lists of
signiﬁcantly altered gene sets for each genotype comparison to
identify which were shared between genotypes and which were
unique to the loss of Gch1 (Supplementary Figure 9a) these new
gene set sub groups were again visualized using Enrichment Map
(Fig. 6c and Supplementary Figure 9B). The majority of gene sets
relating to DNA repair, protein catabolism, vesicular trafﬁcking
and ribosome activity were found to be common to the loss of
either Gch1 or Nos2 (Supplementary Figure 9b). However, a
number of gene signatures were unique to the loss of Gch1
(Fig. 6c, d). These gene sets were related to fundamental cellular
processes such as metabolism and cellular detoxiﬁcation as well as
to processes related to inﬂammation and infection such as
lysosomal function, apoptosis and cell senescence and innate
immune. To conﬁrm the biological relevance and validity of these
ﬁndings, we performed a second round of GSEA using gene sets
relating to canonical pathways and curated datasets (MSigDB C2
CP). This analysis again identiﬁed a number of gene sets that
were either shared by both genotypes or unique to the loss of
Gch1 (Fig. 7 and Supplementary Data 6). Gch1 unique gene sets
again included those related to lysosome function, inﬂammation,
DNA damage response (including p53 pathway) and lipid and
glucose metabolism conﬁrming our ﬁndings.
Gch1ﬂ/ﬂTie2cre macrophages showed reduced IL-6 gene and
protein expression in response to BCG/IFNγ, as predicted by the
pathway analysis (Fig. 8). Under the conditions used for gene
expression analysis no alterations in cell viability were seen
(Fig. 9a). Under conditions of enhanced greater stress, with cells
being infected with BCG/IFNγ (MOI 5:1) we observed a
decreased macrophage cell survival, associated with increased
apoptosis of infected cells, in the absence of Gch1 again
conﬁrming that the gene expression analysis is predictive of
alterations in macrophage cell biology. Gene sets related to the
Sterol/Cholesterol pathway can have multiple effects on cell lipid
handling including altered cholesterol handling and lipid droplet
format, altered oxysterol production and alterations to LXR/RXR
ligands. We tested the ability of BH4 deﬁcient cells to form lipid
droplets in response to BCG/IFNγ, using a recently reported
method and droplet formation still occurred in the absence of NO
(Fig. 9b)31.
Gch1 expression alters mycobacterial growth in vitro. To
determine whether Gch1 and BH4 directly alter control of
mycobacterial infection in macrophages, we infected BMDM
macrophages in vitro with BCG and quantiﬁed the control of
mycobacterial infection using the mycobacterial growth inhibi-
tion assay (MGIA)32. After BCG infection, CFU counts were
signiﬁcantly higher in Nos2−/− macrophages than their wildtype
controls (Fig. 10a). In contrast, Gch1ﬂ/ﬂTie2cre macrophages had
signiﬁcantly lower CFU counts than their wildtype controls
(Fig. 10b). This indicates that BH4-deﬁcient macrophages alone
have an enhanced cell-intrinsic mechanism for control of
mycobacterial growth.
Having shown that Gch1 deletion increases the control
mycobacterial infection by murine macrophages, we next tested
whether a similar association between GCH1 expression and
mycobacterial control is seen in human cells. PBMCs from BCG-
vaccinated infants, from a previously reported vaccine efﬁcacy
study33, were used to perform an in vitro MGIA to assess control
of BCG infection. In parallel, samples were infected with BCG
overnight and underwent analysis for GCH1 and NOS2 gene
expression. There was a signiﬁcant positive correlation between
GCH1 gene expression and increased mycobacterial CFU in the
direct PBMC MGIA assay (Fig. 10c). In contrast, there was no
correlation between NOS2 gene expression and mycobacterial
control (Fig. 10d). Thus, lower GCH1 expression in human
PBMCs is also associated with increased control of mycobacterial
infection, independent of PBMC NOS2 expression.
Discussion
Our ﬁndings suggest that re-evaluation of the role, and
mechanism of action, of NO in macrophage anti-mycobacterial
activity is required. Along with other recent studies our data show
that a direct cytotoxic role for NO within the macrophage is not
the only, and possibly not the main, function for NO34,35. Whilst
direct exposure of mycobacteria to nitric oxide gas has been
conﬁrmed to mediate mycobacterial killing10, our observations
suggest that NO production by leukocyte-expressed iNOS is not
the only mechanism by which iNOS can control M.tb and indeed
a lack of NO maybe beneﬁcial in some circumstances. A rein-
terpretation of the role of NO in TB has important implications
for understanding the apparent discordance between the strong
evidence for iNOS and NO in the control of mycobacteria in
murine models, compared with a less clearly deﬁned role for
iNOS and NO system in human disease18–20. Although iNOS is
expressed in inﬂammatory conditions such as TB21,22 the ability
Fig. 2 Absence of Gch1 improves the resistance of mice to in vivo BCG infection. a The excision of the ﬂoxed Gch1 allele in both cells from WT and
Gch1ﬂ/ﬂTie2cre recovered by bronchial-alveolar lavage (BAL) was conﬁrmed by genomic PCR, with analysis of BMDM used as a positive control for cre
activity: knockout allele (K) ﬂoxed allele (F). The presence or absence of the cre transgene was conﬁrmed using HPRT as a housekeeping gene. b The BH4
(pmol/106cells) content of the BAL cells was analysed by HPLC (n= 4 per genotype, two-tailed t-test, p < 0.05). c, d Gch1ﬂ/ﬂTie2cre (red) and wildtype
(black) mice were infected intranasally with 5 × 106 colony forming units (CFU) BCG Pasteur. Four weeks following infection the lungs and spleen were
removed and homogenised for analysis along with tissues from a matched cohort of uninfected animals. The bacterial load of the organs was enumerated
by CFU count from lung (c) and spleen (d). Each dot represents one animal, line represents median CFU of each group (n= 10 Gch1ﬂ/ﬂ, n= 6
Gch1ﬂ/ﬂTie2cre (Spleen), n= 7 Gch1ﬂ/ﬂTie2cre (Lung) per group), p < 0.01 (Mann–Whitney test). e Spleen to body weight ratio was also calculated.
Remaining tissue homogenate was used to measure total biopterin content, in lungs (f) and spleen (g) (n= 10 Gch1ﬂ/ﬂ, n= 7 Gch1ﬂ/ﬂTie2cre Spleen
(infected) and n= 4/genotype (uninfected), p < 0.05). Total lung biopterin content was correlated to lung CFU in all animals. Pearson r p < 0.05 (h). i iNOS
protein expression was conﬁrmed by western blotting, with ß-tubulin loading control (n= 2 per group shown, representative of n= 3 independent
biological replicates assayed in total). An NO analyzer was used to measure NOx content in the lung homogenates (p < 0.05) (j). All data analsyed with
ANOVA with Bonferroni post-test (apart from (b–d) and (h) as above). Data shown as individual data-points with mean and SEM (apart from (c) and
(d) as above). *p < 0.05. Source gel and blot images are available in Supplementary Figure 10
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of human macrophages to produce nitric oxide is controversial36.
SNPs in the NOS2 gene have been associated with altered sus-
ceptibility to disease, with many identiﬁed SNPs sitting in the
promoter region and associated with increased gene transcription
and associated with protection from TB3. These data do indicate
that alterations in iNOS biology have an impact on human sus-
ceptibility, however our data would suggest that this may not be a
simple association with NO cytotoxicity, but that the relative
expression of NOS2 and GCH1 is likely to be key.
iNOS is expressed in macrophages from TB patients, but
human macrophages exhibit exon skipping during transcription
of 6-pyruvoyl tetrahydropterin synthase (PTPS), the second step
in BH4 production, which leads to low-level production on BH4
in these cells, and accumulation of the proximal metabolite,
neopterin, that has been used as a biomarker in TB37. The GCH1
gene has been identiﬁed as a marker of active disease in TB
patients in several gene expression studies38,39. However, these
studies did not report any further association other than
increased expression in infected individuals, compared to healthy
or disease control patients. In contrast, we now demonstrate that
GCH1 expression, rather than NOS2 expression, correlates with
control of mycobacterial growth in human PBMC. Indeed, a
previous study has reported increased mycobacterial growth in
infected human macrophages in the presence of exogenous
BH4 supplementation40. Thus, human macrophages may share
the NO-independent means of controlling mycobacteria under
conditions of low BH4 availability, suggesting that inhibition of
macrophage BH4 synthesis may provide a therapeutic target for
TB.
INOS is increasingly recognized as having a signaling role in
TB by preventing excessive inﬂammation and tissue damage. A
recent study identiﬁed HIF-1α, downstream of iNOS activation,
as a crucial mediator of IFNγ mediated response to M.tb
infection35,41. Nos2−/− mice were used to demonstrate that iNOS
was a crucial stabilizer of HIF-1α, resulting in increased HIF-1α
signaling41. Genetic deletion of either iNOS or HIF-1α resulted in
reduced control of mycobacteria by macrophages. Critically iNOS
and HIF-1α mediated opposing roles in the regulation of a panel
of pro-inﬂammatory cytokines, including IL-6, IL-1 and neu-
trophil chemokines, indicating iNOS has wider roles in the cell
signaling than via HIF-1α41. The ability of NO to chemically
modify proteins through nitrosylation of cysteine residues is one
way in which iNOS can transduce signals within the cell. In the
case of mycobacterial infection, nitrosylation of NLRP3 prevents
inﬂammasome activation thus reducing the production of
important pro-inﬂammatory mediators such as IL-142. Accord-
ingly IL-1 and lipoxygenase mediated pathways were shown to be
overactive in Nos2−/− mice with the resultant excessive neu-
trophil recruitment and tissue damage supporting enhanced
mycobacterial growth34. BH4 deﬁcient NO-deﬁcient macro-
phages, appear to show transcriptional changes in similar gene
sets and molecules highlighted in earlier studies in Nos2−/− cells
and tissues34,41. Intriguingly, cellular pathways identiﬁed through
analysis of iNOS protein–protein interactions17, namely riboso-
mal and proteosomal pathways, are found amongst the shared
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Fig. 3 Absence of Gch1 increases resistance of mice to virulent M.tb
infection. Gch1ﬂ/ﬂTie2cre (red) and wildtype (black), Nos2−/− (green) and
Nos2+/+ (blue) mice were infected with 150 CFU M.tb (Erdman strain) by
aerosol inhalation. 23 days following infection the lungs and spleen were
removed for analysis. Representative organs were imaged from each
genotype prior to n= 2 tissues per genotype being embedded for
histochemical analysis. Sections were cut from all tissues and stained with
H&E or subjected to anti-iNOS immunohistochemistry (a). Animals were
weighed at regular intervals throughout the experiment and the mean
weight change and SEM per group was plotted (b). Lungs and spleen were
homogenised and the mycobacterial load of the organs was enumerated by
CFU count from lung (c) and spleen (d) (n= 8 per group, * p < 0.01)
(Mann–Whitney). Each dot represents one mouse, line in each group
represents the median CFU. e Weights negatively correlated with CFU
counts. Pearson r p < 0.05. f Gch1ﬂ/ﬂTie2cre (red) and Gch1ﬂ/ﬂ (black) mice
were infected as before but this time lungs and spleen were removed
6 weeks following infection for analysis. Lungs and spleen were
homogenised and the mycobacterial load of the organs was enumerated by
CFU count from lung (f) and spleen (g) n= 7 Gch1ﬂ/ﬂ, n= 8 Gch1ﬂ/ﬂTie2cre,
*p < 0.01 (Mann–Whitney). The ﬁnding in (f) was replicated on two
occasions in independent experiments. Scale bars: upper panels 0.5 cm,
lower panels 100 um
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gene sets found in both BH4-deﬁcient and iNOS-deﬁcient mac-
rophages, hinting that NO production by iNOS may also mod-
ulate its interaction with other proteins. The endothelin system is
a key effector of NOS enzymes in other cell types and also showed
alterations in gene expression levels in the absence of BH4, but
expression of both protective (ET-1) and non-protective (ETB)
elements of the system were downregulated43. So whilst some
signaling functions attributed to iNOS are linked to nitric oxide,
the potential contribution of other signaling pathways is over-
looked. The critical difference between our study and previously
published analyses of the Nos2−/− mouse is that selective mac-
rophage BH4 deﬁciency results in loss of NO production, rather
than loss of all potential iNOS functions, and this results in
increased control of mycobacterial infection.
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The loss of macrophage BH4 is sufﬁcient to enhance control of
mycobacterial infection by the cell itself. Upon infection with
mycobacteria, mycobacterial killing is assumed to occur by the
maturation of the uptake phagosome and fusion with the lyso-
some to form the phagolysosome44. While the cytotoxic capacity
of the cell was assumed to then reside in the ability to produce
RNI and ROS species, increasingly evidence suggests this is not
the case. The role of ROS in direct mycobacterial control is as
controversial as the role of nitric oxide. The loss of ROS pro-
duction in p47PHOX−/− mice resulted in only a transient decrease
in bacterial control, and human chronic granulomatous disease
patients, who lack myeloid cell ROS production, do not show
increased susceptibility to TB45,46. An interpretation of our
ﬁndings is that Nos2−/− cells lack all aspects of iNOS activity
(both NO and ROS-mediated), whereas Gch1ﬂ/ﬂTie2cre cells lack
NO production but have preserved ROS production, that may
mediate mycobacterial killing. A direct effect of ROS on myco-
bacterial killing seems less likely, given both the complicated
pattern of altered ROS production in the absence of BH4 and
equivocal evidence for mycobacterial killing by ROS. Never-
theless, altered ROS production may exert important effects
through altered downstream redox signaling. Increasingly the fate
of lysosomal bacteria through the engagement of autophagy and
intracellular degradation machinery is highlighted as playing a
role in bacterial killing44,47,48. Similarly macrophage cell death by
apoptosis is associated with decreased viability of
mycobacteria49,50. The extent to which ROS, nitric oxide and
iNOS act as signaling molecules in coordination of these
responses may link older and newer ﬁndings. The altered lyso-
somal function and cell survival signals we identiﬁed in Gch1
deﬁcient macrophages could clearly have implications for
mycobacterial control. Additionally, a BH4 speciﬁc alteration in
metabolic and mitochondrial gene sets in infected macrophages,
has similar potential as M.tb causes a profound shift in cellular
metabolism towards aerobic glycolysis, which was evident in
leukocytes within the lung51. Control of mycobacterial infection
downstream of IFNγ and iNOS was shown to involve activation
of aerobic glycolysis, which ampliﬁed macrophage activation35.
Induction of aerobic glycolysis by human macrophages following
mycobacterial infection is reported to facilitate control of bac-
terial replication, with inhibition of this process associated with
enhanced mycobacterial survival52. As extracellular H2O2 accu-
mulation has been linked with activity of the mitochondrial
electron transport chain the altered H2O2 accumulation seen
following infection in this study may indicate metabolic changes
in the absence of macrophage BH453.
We have used a genetic approach to identify new mechanisms
linking macrophage iNOS and NO to the control of myco-
bacterial infection in vitro and in vivo, using cell-speciﬁc BH4
deﬁciency, achieved by conditional Gch1 deletion. NOS enzymes
can function independently of NO both through protein–protein
interactions and in an ‘uncoupled’ state in the absence of BH4,
whereby L-arginine is not oxidized to NO and superoxide is
produced by the reductase domain of the enzyme14,15,17. Thus,
equating NOS activity with nitric oxide production alone
potentially overlooks important alternative signaling pathways.
Whilst these pathways are dominated by superoxide production
from NOS in other BH4-deﬁcient NOS expressing cells, such as
endothelial cells28, the redox biology of macrophages lacking BH4
appears more complex. It has previously been reported that BH4
has important effects on cellular metabolism independent of its
effect on NOS biology54. Knockdown of Gch1 in the absence of
any NOS expression resulted in alterations in bioenergetic
metabolism54. So whilst the transcriptional effects seen on mac-
rophage metabolism may be important, these may not all be
dependent iNOS expression. Tetrahydrobiopterin has other NOS-
independent functions as it is also a co-factor for other enzymes
such as alkylglycerol monooxygenase (AGMO), which modulates
cellular lipid signaling, and catecholamine-related enzymes15,55.
These NOS-independent roles for BH4 in macrophage biology
are still of particular relevance to humans due to the low levels of
BH4 present in human macrophages, such that alterations in cell
function relating to both reduced NO-production from iNOS and
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Fig. 5 Divergent gene expression changes in BH4 and iNOS-deﬁcient
macrophages. BMDM were prepared from Gch1ﬂ/ﬂ, Gch1ﬂ/ﬂTie2cre, Nos2+/+
and Nos2−/− age-matched animals. Macrophages were infected at a MOI
of 1:1 with BCG in the presence of 10 ng/ml IFNγ, or left uninfected followed
by RNA extraction. Gene expression was quantiﬁed using TaqMan gene
expression assays. GOI Gene of Interest. Data was analysed by two-tailed
T-test * p < 0.05, error bars ± SEM
Fig. 4 Absence of Gch1 alters macrophage gene expression in response to infection. Macrophages were infected with BCG (MOI 1:1)/IFNγ (10 ng/ml) for
24 h or incubated for 24 h in the absence of infection (n= 4 per genotype). RNA was extracted and a whole mouse genome gene expression array was
performed. a Genes were determined as signiﬁcantly regulated by genotype by comparison to their relevant wildtype control with p < 0.05 (adjusted for
multiple testing). The number of genes signiﬁcantly regulated by genotype for each condition was calculated. The number of genes shared between
genotypes and conditions is shown by Venn Diagram. b Selected relevant gene functional annotations determined with signiﬁcantly increased or decreased
expression in BCG infected wildtype vs Gch1ﬂ/ﬂTie2cre macrophages, as determined using IPA analysis with Z score > 2 and a p-value for overlap p < 0.01.
c Heatmaps for genes within individual gene functional annotations determined in (c, d). d Selected relevant predicted upstream regulators with
signiﬁcantly increased or decreased activation in BCG infected wildtype vs Gch1ﬂ/ﬂTie2cre macrophages, as determined using IPA analysis with Z score > 2
and a p-value for overlap p < 0.01
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iNOS-independent BH4-dependent changes in macrophage
biology have key translational relevance.
We demonstrate an unanticipated aspect of BH4/iNOS biology
that mediates enhanced control of mycobacterial infection
through mechanisms that are independent of iNOS-mediated NO
production. Gch1 and BH4 exert striking effects on the control of
mycobacterial infection in macrophages independent of
NO-production, in both mice and humans. The BH4-deﬁcient
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Fig. 6 GSEA identiﬁes unique gene expression patterns in Gch1 cells. Gene expression data from both Gch1 and Nos2 deﬁcient macrophages were analysed
for GO term (biological processes) enrichment by Preranked gene-set enrichment analysis (GSEA) vs their wildtype control. The result was visualized as a
network of gene sets (nodes) connected by their similarity (edges), compiled in Cytoscape using the Enrichment Map plug in. Node size represents the
gene-set size and edge thickness represents the degree of overlap between neighboring gene sets. The GSEA output ﬁles were given analysed with a
statistical cutoff set at p < 0.005 and FDR q < 0.1. The individual Enrichment Maps were plotted in Cytoscape for infected a Gch1 and b Nos2 macrophages
and clusters were annotated by hand. To determine if regulated genesets were shared between the Gch1 and Nos2 knockout macrophages the signiﬁcantly
regulated gene sets were compared and a subset of genesets unique to Gch1 deﬁcient macrophages was created, this subset (c) was plotted using
Enrichment Map and the clusters annotated. d A table summarizing the GO-term clusters, with exemplar GO terms
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Gch1ﬂ/ﬂTie2cre mouse may provide a better in vivo model to
investigate novel human therapeutics and vaccinations than
either wildtype mice, or Nos2−/− mice, due to the strong parallels
with human macrophage biology. Exploiting this model could
provide novel targets for HDT to control mycobacterial infection
that are not possible to study in traditional models.
Methods
Infant PBMC samples. The correlates of risk samples used in this study formed
part of larger cohort from a phase IIb efﬁcacy trial (ClinicalTrials.gov number
NCT00953927)33. The trial was approved by the University of Cape Town, Faculty
of Health Sciences, Human Research Ethics Committee, Oxford University Tro-
pical Research Ethics Committee and the Medicines Control Council of South
Africa. Informed consent was obtained from the mothers of all infants. Brieﬂy,
2797 healthy infants (4–6 months) who had received BCG vaccination within
7 days of birth were randomly divided into either receiving MVA85A (n= 1399) or
Candida as placebo (n= 1398). Infants were monitored for up to 37 months. The
primary outcome of this study was safety but the efﬁcacy of MVA85A vaccine was
also assessed, with primary study endpoint the incidence of tuberculosis. MVA85A
did not signiﬁcantly improve BCG efﬁcacy (17.3%, 95% CI −31.9 to 48.2). Some of
these samples were used in an identiﬁcation of correlates of risk study (n= 258)56.
A number of assays (on a priority list) were performed on whole blood and PBMC
samples from day of enrolment (D0) and 28 days post vaccination (D28). The
MGIA assay was only performed if enough cells were available. For the analysis in
this manuscript, PBMC samples (n= 78) from D0 were used to avoid confounding
effects of MVA85A vaccination.
Animal studies. All animal studies were conducted with ethical approval from the
Local Ethical Review Committee at the University of Oxford and in accordance
with the UK Home Ofﬁce regulations (Guidance on the Operation of Animals,
Scientiﬁc Procedures Act, 1986). Mice were housed in ventilated cages with a 12-h
light/dark cycle and controlled temperature (20–22 °C), and fed normal chow and
water ad libitum. For in vivo experiments adult female mice >10 weeks of age were
used for all studies, whole litters were randomly assigned to experimental groups,
with heterozygous breeding strategies providing a mix of genotypes within each
litter. Experiments using littermate animals were performed blinded to the geno-
types of the individual animals. For homozygous strains in vivo experiments were
blinded to the genotype by labeling of the cages by a group code, rather than
genotype. Mice had received no prior procedures (including acting as breeding
stock) prior to use in experiments for this manuscript.
Gch1ﬂ/flTie2cre and Gch1ﬂ/ﬂ mice. A novel mouse model of BH4 deﬁciency was
created by conditional deletion of Gch1, that encodes GTP cyclohydrolase I the
rate-limiting enzyme in BH4 biosynthesis. Exons 2 and 3 of Gch1, encoding for the
active site of GTPCH protein, were ﬂanked by loxP sites in a targeting construct
that was used to produce Gch1ﬂ/ﬂ mice following homologous recombination in ES
cells. Mice have been backcrossed for >8 generations to C57BL/6J. These mice were
crossed with Tie2cre transgenic mice to produce Gch1ﬂ/ﬂTie2cre mice where Gch1
is deleted in endothelial and bone marrow-derived cells28. The Tie2cre transgene is
active in the female germline, as such only male Tie2cre heterozygote animals are
used to establish breeding pairs to maintain conditional expression. Mice were
genotyped using primers targeted against the ﬂoxed Gch1 allele, and in a separate
reaction for the presence of the cre sequence. Experiments were performed using
bone marrow isolated from adult (>10-week old) female littermate animals. Ani-
mals were genotyped using DNA prepared from ear notches using the following
PCR primers:
Cre:
5′ GCATAACCAGTGAAACAGCATTGCTG 3′
5′ GGACATGTTCAGGGATCGCCAGGCG 3′
Gch1 ﬂoxed allele:
5′ GTCCTTGGTCTCAGTAAACTTGCCAGG 3′
5′ GCCCAGCCAAGGATAGATGCAG 3′
Nos2−/− mice. Nos2−/− mice and C57BL/6J control mice were obtained from
Jackson Labs (Bar Harbor, US) and Charles River (UK)57. Experiments were
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Fig. 9 BH4 deﬁciency alters infected cell viability. a Gch1ﬂ/ﬂTie2cre and Gch1ﬂ/ﬂ macrophages were stimulated IFNγ (10 ng/ml) and BCG (MOI 1:1 or 5:1) or
left untreated overnight. At the end of the assay the cells were harvested and incubated in buffer containing 7AAD and Annexin V-APC for 15 min at room
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V+/7AAD+. Infection was conﬁrmed by detection of GFP and early apoptosis (Annexin V+/7AAD−) was assessed in BCG-GFP+ cells infected at MOI 5:1.
Data was analysed by 2-way ANOVA *p < 0.05 with Bonferroni post-test or two-tailed t-test (n= 5/genotype). b Gch1ﬂ/ﬂTie2cre and Gch1ﬂ/ﬂ macrophages
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performed using bone marrow isolated from adult (>10-week old) female littermate
animals.
Isolation of murine bone marrow-derived macrophages. Bone marrow was
obtained by ﬂushing the femur and tibia of adult female mice with PBS. A single
cell suspension was prepared by passing the bone marrow through a 70 µm cell
strainer. Cells were then cultured in 10 cm non-tissue culture treated dishes for
7 days in DMEM:F12 (Invitrogen) supplemented with 100 U/ml penicillin and
100 ng/ml streptomycin (Sigma), 10% (v/v) fetal bovine serum (PAA Laboratories),
5 mM L-glutamine (Sigma) and 10–15% (v/v) L929 (ATCC NCTC clone 929)
conditioned medium at 37 °C and 5% CO2. The protocol for macrophage culture
was validated by ﬂow cytometry analysis of the differentiated cells using f4/80 and
CD11b as macrophage cell markers.
Blood, bone marrow and spleen leukocytes. Single cell suspensions of spleno-
cytes and bone marrow cells were obtained using standard protocols58. Blood
samples were taken directly into an EDTA coated tube (Teklab). All cell popula-
tions were stained with monoclonal antibodies directed against CD11b PerCP-
Cy5.5 (550993), CD4 AF647 (557681), CD8 FITC(553030), CD3 Paciﬁc Blue
(558214), B220 PE(553089), Ly-6G FITC(561105) (all BD Biosciences, 1/200) and
the 7/4 antigen PE (MCA771PE, AbD Serotech, 1/50). The total cell population was
gated by forward scatter and side scatter then interrogated for expression of the
relevant cells markers compared to isotype controls (T-cells—CD3+, B-Cells—
B220+, Neutrophils—7/4HI, Ly-6G+ or Monocytes—7/4HI, Ly-6G−). Cells were
enumerated by an absolute count as described below.
Zymosan-induced peritonitis. Mice were injected with 1 mg zymosan (Sigma) in
500 µl PBS using an insulin syringe. After 6 h mice were lavaged post-mortem with
ice-cold PBS/EDTA (5 mM), lavage ﬂuid was injected using a 25 G needle, the
cavity mixed by agitation, and then lavage ﬂuid was withdrawn using a 21 G needle.
Cell recruitment was assessed by ﬂow cytometry using 7/4-PE and Ly-6G-FITC
using an absolute cell count method as below. Total cell recruitment was calculated
as the total cells that would be recovered in the 5 ml lavage volume.
Bacterial culture. BCG Pasteur (ATCC 35734) was grown in-house in Mid-
dlebrook 7H9 Broth (BD, UK) supplemented with Middlebrook ADC +0.05%
Tween 80. Erdman K01 (TMC107) was provided by BEI Resources (NR-15404, BEI
Resources; Manassas, USA). BCG-GFP was grown under the same conditions but
in the presence of Hygromycin B (50 μg/ml) to select GFP expressing bacteria.
Flow cytometry. All ﬂow cytometry was performed using a DAKO CyAn cyt-
ometer and Summit software (both Beckton Coulter). Data was analysed using
Flow Jo software (TreeStar Inc). Where cells were enumerated using an absolute
count protocol with cells quantiﬁed by ratio to a known number of ﬂuorescent
beads spiked into the sample prior to analysis.
Stimulation of bone marrow-derived macrophages. Following differentiation
cells were harvested and plated into 6 or 12 well plates in serum-free media
(Optimem supplemented and 0.2% (w/v) low-endotoxin bovine serum albumin
(Sigma)). Cells were stimulated with BCG at a MOI of 1:1 in the presence of
10 ng/ml murine IFNγ (Peprotech EC) for 24 h, parallel wells were left unstimu-
lated. After 24 h cell pellets and cell culture supernatants were collected, or the cells
subjected to biochemical analysis.
Genomic DNA production and excision PCR. Genomic DNA for detection of the
excised allele was produced using the Qiamp kit (Qiagen). The ﬂoxed and excised
allele were detected using the following primers:
5′GTCCTTGGTCTCAGTAAACTTGCCAGG3′
5′GCCCAGCCAAGGATAGATGCAG3′
5′GCTCATCCCCCACACTTGTCTT3′
The ﬂoxed allele yields a 1030 bp product and the excised allele a product of
1300 bp.
Determination of tetrahydrobiopterin levels. BH4 and oxidized biopterins (BH2
and biopterin) were determined by high-performance liquid chromatography
(HPLC) followed by electrochemical and ﬂuorescent detection, respectively59. Cell
pellets were freeze-thawed in ice-cold resuspension buffer (50 mM phosphate-
buffered saline, 1 mM dithioerythritol, 1 mM EDTA, pH 7.4). After centrifugation
at 13,200 rpm for 10 min at 4 °C, supernatant was removed and ice-cold acid
precipitation buffer (1 M phosphoric acid, 2 M trichloroacetic acid, 1 mM
dithioerythritol) was added. Following centrifugation at 13,200 rpm for 10 min at
4 °C, the supernatant was removed and injected onto the HPLC system. Quanti-
ﬁcation of BH4 and oxidized biopterins was obtained by comparison with external
standards and normalized to protein concentration, determined by the BCA pro-
tein assay. Total biopterins (BH4+ BH2+ biopterin) were quantiﬁed where sig-
niﬁcant BH4 oxidation might be expected to occur in extracellular ﬂuids/peritoneal
lavage or unperfused whole tissue homogenates subjected to harsh homogenization
for CFU quantiﬁcation.
Nitrite and NOx determination. Nitrite accumulation was measured in samples of
cell culture medium using the Griess Assay with colorimetric detection in 96-well
plates. Cell culture supernatants were mixed 1:1 with the Griess reagent (Sigma)
and quantiﬁed by comparison to a sodium nitrite (Sigma) standard curve produced
in tissue culture media. Measurement of NOx in lavage ﬂuid was made using a
Nitrite/Nitrate kit (Cayman Chemicals, US). Analysis of NOx in lung homogenates
was performed using a CLD88 NO analyzer (Ecophysics).
Electron paramagnetic resonance. Cultured macrophages were incubated with
colloid iron (II) diethyldithiocarbamate [Fe(DETC)2] (285 µmol/L) at 37 °C for
90 min. After incubation, cells were harvested and snap-frozen in a column of
Krebs-HEPES buffer in liquid nitrogen, and EPR spectra were obtained using an
X-band EPR spectrometer (Miniscope MS 200; Magnettech). Signals were quan-
tiﬁed by measuring the total amplitude, after correction of baseline, and after
subtracting background signals from incubation with colloid Fe(DETC)2 alone.
Dihydroethidium HPLC. Cultured macrophages were incubated with 25 µM DHE
(Invitrogen) for 30 min before being harvested for separation of DHE using gra-
dient HPLC system (Jasco, UK) with an ODS3 reverse phase column (250 mm,
4.5 mm, Hichrom, UK) and quantiﬁed using a ﬂuorescence detector set at 510 nm
(excitation) and 595 nm (emission). Samples for injection were prepared by lysing
the cell pellets in ice-cold methanol and removing protein by acid precipitation
with 0.1 M HCl.
BCG intranasal infection. For intranasal (i.n.) infection, animals were sedated
using IsoFlo (Oxford University Veterinary Services; UK) and inoculated with
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Fig. 10 Gch1 expression inversely correlates with control of BCG infection
in vitro. a, b A mycobacterial growth inhibition assay was performed using
Nos2−/− (a) and Gch1−/ (b) BMDM cells. Macrophages were infected with
50:1 MOI BCG in the presence of 10 ng/ml IFNγ and the live BCG remaining
after 96 h was enumerated by the BACTEC Mycobacterial Growth Indicator
Tube (MGIT) system (MGIA), n= 6 per genotype Nos2+/+ and Nos2−/−,
n= 5 Gch1ﬂ/ﬂ and n= 5 Gch1ﬂ/ﬂTie2cre n= 7 p < 0.05 (t-test), individual
points with SEM shown. Δlog10CFU= log10 CFU sample− log10 CFU
positive control. Error bars are ±SEM. c, d Pearson correlation between
GCH1 expression and in vitro BCG growth in PBMCs of 78 BCG vaccinated
South African infants. Points represent the mean of duplicate cultures.
Δlog10CFU (M.BCG)= log10 CFU of sample− log10 CFU of control
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5 × 106 CFU BCG through the nostrils (25 μl/nostril). Four weeks after infection,
mice were sacriﬁced and lung and spleen were aseptically removed.
M.tb aerosol challenge. Mice were challenged using a Biaera AeroMP-controlled
nebuliser (Biera Technologies; Hagerstown, USA) contained in a Category Level 3
TCOL isolator. Animals were loaded in nose-only restrainers and exposed to
aerosolised Erdman K01 (TMC107) (BEI Resources; Manassas, USA), prepared at a
5 × 106 cfu/ml in the nebuliser. The program was run for 10 min plus a 5 min purge
with the airﬂow set to 12 L/min at a pressure of 20 psig. The target dose of 100–200
CFU/animal was conﬁrmed by sacriﬁcing two infected animals from each run 24 h
post-challenge. For M.tb. challenge studies 8 mice per group were used. Experi-
ments were designed to have 75% power to detect differences between groups,
based on a p value of 0.05.
Mycobacterial growth inhibition assay. BMDM from all four genotypes were
prepared as above. Cells were treated with IFNγ (10 ng/ml) and BCG-Pasteur with
a MOI of 50:1. The tubes were incubated at 37 °C on a 360° rotator for 96 h. In
parallel, a positive control was set up, by adding the same inoculum of BCG, but no
cells, in a BACTEC MGIT tube (BD) supplemented with OADC/PANTA sup-
plement (BD). After incubation, sample tubes were spun at 12,000 rpm for 10 min,
and cells were lysed with 500 μl of water (Sigma) for 10 min, vortexing twice in
between. The resulting solution was transferred into a supplemented MGIT and
incubated until positive in a BACTEC MGIT 960 machine. Data are expressed as
Δlog10 CFU which is log10 CFU of a sample subtracted by log10 CFU of positive
control.
Quantiﬁcation of CFU. Lungs and spleens of infected animals were harvested after
challenge. Organs were homogenised in re-inforced tubes with ceramic beads
containing 1 ml PBS using Precellys 24 (Stretton Scientiﬁc, UK). Homogenised
organs were diluted in PBS and dilutions were plated in Middlebrook 7H10 plates
(BD), containing OADC (BD Diagnostic Systems). Plates were incubated at 37 °C
and counted 3 weeks later.
Histology and immunohistochemistry. For TB infected lungs, histology mice
were sacriﬁced by cervical dislocation, a slit was created in the trachea and one lung
lobe placed in PBS for conﬁrmation of CFU. A tube was inserted in the trachea and
lungs were inﬂated with 1 ml of 10% Neutral Buffered Formalin (NBF; Sigma
Aldrich, UK). The lungs were removed and placed in 10 ml of NBF overnight at
4 °C and then transferred into 70% ethanol and stored at 4 °C.
Parafﬁn-embedded tissue samples were sectioned (7 μm) and stained with
hematoxylin and eosin (Sigma) and Acid Fast stain (BD Biosciences).
Immunohistochemical staining was performed using anti-iNOS antibody (sc-651,
Santa Cruz, 1/500) and anti-Galectin 3 (AF1197, R&D Systems, 1/500). This was
followed by a secondary biotinylated antibody (Vector Laboratories, UK) then
avidin–biotin–AP complex and visualized with Vector Red alkaline phosphatase
substrate (Vector Laboratories, UK).
Western blot analysis. Western blot analysis was performed using antibodies
against murine GTPCH (a gift from S. Gross, Cornell University New York, 1/500),
iNOS (610329 BD Pharmigen, 1/1000) and β-Tubulin (ab6046, Abcam, 1/50,000),
using standard protocols.
Quantitative real-time RT-PCR. RNA was prepared using the RNeasy kit (Qia-
gen) and was reverse transcribed using Superscript II (Life Technologies). 50 ng
RNA equivalent cDNA was used to perform real-time PCR using pre-designed
Taq-Man gene expression assays (Gch1: Mm01322973_m1, Nos2:
Mm00440502_m1, TNFα: Mm00443258_m1, Life Technologies) using a BioRad
CFX1000. Gene expression data was normalized to β-actin expression (4352341E,
Life Technologies) using 2−(B-actinCT-Gene of interestCT).
IL-6 ELISA. Cell supernatants were harvested and cell debris removed by pelleting
at 13,000 rpm in a microfuge. Appropriate dilutions of the supernatant media were
performed and samples were analysed using an ELISAMAX Mouse IL-6 ELISA
according to the manufacturer’s instructions (Biolegend, UK).
Oxidative burst. Cells were infected with BCG-GFP/IFNγ for 2 h in antibiotic-free
media supplemented with 2% FCS (to increase opsonisation) and then stained with
2.5 μM CellROX spiked into the media. After 30 min cells were rapidly detached in
PBS/EDTA by scraping and cell ﬂuorescence was analysed by ﬂow cytometry.
Hydrogen peroxide measurements. Cell free supernatants were subjected to
amperometric measurement of hydrogen peroxide using a Hydrogen Peroxide
Microsensor electrode and Free Radical Analyser system (WPI, UK).
Apoptosis. Cells were infected with BCG-GFP/IFNγ for 2 h in antibiotic-free
media supplemented with 2% FCS (to increase opsonisation) and then harvested
using ice-cold PBS/EDTA 5mM. Cells were washed and stained with an 7AAD and
Annexin V-APC apoptosis kit according to the manufacturer’s instructions (Bio-
legend, UK).
Lipid droplet formation. Cells were infected with BCG-GFP/IFNγ overnight in
antibiotic free media supplemented with 2% FCS (to increase opsonisation and as a
lipid source). Cells were washed and ﬁxed with 4% PFA for 15 min. Cells were then
washed and incubated in PBS containing LipidTOX Red Neutral Lipid Stain
(Invitrogen, UK) at 1:500 dilution for a minimum of 30 min. Nuclei were costained
using 1 μg/ml DAPI (Merck, UK) and cells were imaged in glass cover-slip bot-
tomed dishes without mounting using an inverted confocal microscope. (LSM510,
Carl Zeiss, Germany).
Human PBMC MGIA. For the mycobacterial growth inhibition assay, 1 × 106
PBMC were inoculated with ~600 CFU of BCG Pasteur in a volume of 600 μl cell
culture medium (RPMI-1640 containing 10% pooled human serum, 2 mM l-
glutamine and 25 mM HEPES). Samples were cultured in duplicate in 2 ml screw-
cap microtubes and incubated at 37 °C for 96 h with 360° rotation. Cells were then
lysed using sterile water, and the lysate transferred to a BACTEC MGIT tube
supplemented with PANTA/enrichment supplement (Becton Dickinson, UK). The
tubes were placed in a BACTEC MGIT 960 and incubated until positivity. The time
to positivity (TTP) was then converted to log10 CFU using stock standard curves of
TTP against inoculum volume and CFU. For each batch of samples, a direct-to-
MGIT control was run in duplicate to correct for day-to-day variability in
inoculum using the following calculation: log10 CFU of sample− log10 CFU of
growth control.
Human gene expression microarrays. Microarrays on the infant PBMC samples
were performed as described previously60. Brieﬂy, RNA was extracted from thawed
PBMCs using the RNeasy kit (Qiagen) according to manufacturer’s instructions.
mRNA was ampliﬁed using the Illumina Total prep kit (Ambion) according to
manufacturer's instructions. RNA was labelled and hybridised to Illumina Human
HT-12 v4 beadchips which were scanned on an Illumina iScan machine and data
were extracted using the GenomeStudio software. Raw, probe level summary values
were imported into R using beadarray61. Probes were background corrected using
negative control probes followed by quantile normalization using the neqc
command62.
Mouse gene expression microarray analysis. Total RNA was extracted from
each sample using a mirVANA kit (Ambion). RNA was quantiﬁed using a
nanodrop spectrophotomoter and adjusted to 100 ng/ul. RNA quality control was
performed using an Aglient Tape Station to conﬁrm RNA integrity and con-
centration. RNA was reverse transcribed, converted into labelled cRNA, frag-
mented and used for hybridization. A genome wide analysis of gene expression was
performed by hybridising the total RNA samples using the GeneChip WT PLUS
assay for GeneTitan on the Mouse Gene 1.1 ST 16-Array plate system. The
Affymetrix Genechip Command Console software 4.0 for GeneTitan was used to
carry out QC checks of the procedure and produce reports.
Data underwent variance stabilization and normalization (VSN) algorithm
using Limma63. Normalized data were imported to Bioconductor (R version 2.14)
(Biobase) and comparison by genotype was performed for each condition (infected
and control) to identify signiﬁcantly differentially expressed genes passing a false
discovery rate of < 0.0564. The effect of infection was conﬁrmed by comparison
within the wildtype animals for infected vs control. The lists of differentially
expressed genes were then subject to IPA pathway analysis (Ingenuity Systems,
http://www.ingenuity.com). Due to the large number of signiﬁcantly regulated
genes for the effect of infection the top 2538 most signiﬁcant genes were used for
IPA analysis (p < 1 × 10−7). For analysis of the effect of loss of gch1 or nos2 those
genes passing adj p < 0.05 were used. Analysis of gene function or upstream
regulators was performed and categories with Z score > 2/−2 (allowing
directionality to be determined) and an overlap p value < 0.05 were considered
signiﬁcant.
For Gene Set Enrichment Analysis (GSEA) preranked lists for the effect of
genotype within infected samples were created. GenePattern v3.9.10 (Broad
Institute) was used and lists were subjected to analysis the GSEAPreranked module
using the GO biological processes gene sets (C5 BP) and Curated Pathways (C2
CP) from the Molecular Signature Database v6.0 (MSigDB)65–67. Gene Sets with a
FDR q < 0.1 and p value p < 0.005 were considered signiﬁcant in this analysis and
used in further analyses. Network analysis of signiﬁcantly regulated gene sets (p <
0.005 and FDR q < 0.1) was performed using Cytoscape v3.5.1 and the Enrichment
map plugin30,68,69, the Enrichment Map default overlap coefﬁcient of 0.5 was used,
as described in ref. 30. To create a list of gene sets unique to the loss of Gch1 any
genes passing p < 0.005 and FDR q < 0.1 present in both Gch1 and Nos2 deﬁcient
macrophage analyses were removed from the Gch1 list and the remaining gene sets
replotted in Cytoscape.
Quantiﬁcation and statistical analysis. Statistical signiﬁcances are indicated in
ﬁgures (∗p < 0.05) and mentioned in the ﬁgure legends. Data were statistically
signiﬁcant when p < 0.05. Statistical tests used are indicated in the ﬁgure legends
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07714-9
14 NATURE COMMUNICATIONS |          (2018) 9:5409 | https://doi.org/10.1038/s41467-018-07714-9 | www.nature.com/naturecommunications
and were calculated with Graph Pad Prism 6. Venn Diagrams were produced using
BioVenn.nl70. Indicated n-values in ﬁgure legends represent individual biological
replicates, i.e. individual mice or cell culture derived from different individuals. Bar
chart and individual point data are expressed as mean ± SEM, unless stated in the
ﬁgure legends. Comparisons between WT and GCH1ﬂ/ﬂTie2cre were made by two-
way ANOVA with Bonferroni post-tests between individual groups or two-tailed t-
test (2 sample groups). Where two sample groups were compared by unpaired t-
test an F test was also performed to compare variance, where this indicated that
variances were signiﬁcantly different Welch’s corrected t-test was used. In this
study Welch’s correction was applied to gene expression data. Time course studies
were compared by ANOVA for repeated measurements. CFU studies were ana-
lysed by Mann–Whitney test, with statistical outliers identiﬁed using Grubb’s test
and removed from the dataset. In this case a single value was removed from the
spleen CFU values in Fig. 2. Correlation data was analysed using Pearson’s cor-
relation coefﬁcient within Prism 6, both r2 and p value are reported.
Data availability
For the human studies, raw and normalized expression data have been deposited at
Gene Expression Omnibus under the accession number GSE98550. For the mouse
studies, raw and normalized expression data have been deposited at GEO under the
accession number GSE107543. Source data for western blot and DNA gels and ﬂow
cytometry gating in Figures 1 and 2 is available in the supplementary methods ﬁle.
Full lists of genes and genesets passing signiﬁcance thresholds are provided as
supplementary datasets. A reporting summary for this article is available as a
Supplementary Information ﬁle.
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